<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-H377VQDL</identifier><date>2015</date><creator>Hadda, Taibi Ben</creator><relation>documents/doc/H/URN_NBN_SI_doc-H377VQDL_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-H377VQDL_001.txt</relation><format format_type="issue">3</format><format format_type="volume">62</format><format format_type="type">article</format><format format_type="extent">str. 679-688</format><identifier identifier_type="ISSN">1318-0207</identifier><identifier identifier_type="COBISSID">283085056</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-H377VQDL</identifier><language>eng</language><publisher>Slovensko kemijsko društvo</publisher><source>Acta chimica slovenica</source><rights>BY</rights><subject language_type_id="slv">koordinacijske spojine</subject><subject language_type_id="slv">modeli</subject><subject language_type_id="slv">organska kemija</subject><subject language_type_id="slv">protitumorske lastnosti</subject><subject language_type_id="slv">rutenij</subject><subject language_type_id="slv">rutenij-stavrosporin kompleksi</subject><subject language_type_id="slv">stavrosporin</subject><title>Computational POM and DFT Evaluation of Experimental in-vitro cancer inhibition of staurosporine-ruthenium(II) complexes</title><title>the power force of organometallics in drug design</title></Record>